You can hardly go out these days without people whispering about who is on the drug, says Amira Arasteh, who, like many, is ...

The rise of weight-loss medications like Ozempic caused a divide in Holly ... a sad pendulum swing in our broader culture around body acceptance. And now with the readily available nature of ...

This could be attributed to a combination of factors, including the influence of social media ... over the past couple of years, the use of Ozempic and other injectable GLP-1 drugs for weight ...

With social media feeds flooding with before and after pictures and Ozempic being the topic for ... Wives," can amplify ...

Influencers who once championed "fat acceptance" are now subject to backlash from the very communities they helped build. Plus-sized model Ella Halikas, who took Ozempic to manage polycystic ovary ...

Amy Kane is a poster girl for trendy weight loss shots like Ozempic, having dropped from ... who has become something of a viral sensation on social media for her dramatic “before and after ...

When you hear Ozempic, do you associate it with the weight-loss trends seen on social media? I used to. However, I soon found that this medication impacts more than just health; it also has ...

In a world increasingly shaped by social ... drugs like Ozempic, hailed as a revolutionary aid for those who can afford it. Conversely, the body positivity movement encourages self-acceptance ...

The weight loss medication taking Hollywood and social media by storm has a lesser-known complication that’s causing concern among users. While Ozempic has helped thousands achieve significant ...

What is it? A medication called semaglutide, which is sold under different brand names, including Ozempic, approved in 2017 for treating type 2 diabetes, and Wegovy, approved just last year for ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...